Pankaj Bhargava

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

Hedy L. Kindler, Donna Niedzwiecki, Donna Hollis et al. · Journal of Clinical Oncology · 2010 · 837 citations · Full text

Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

Andrew X. Zhu, Dushyant V. Sahani, Dan G. Duda et al. · Journal of Clinical Oncology · 2009 · 473 citations · Full text

Phase II Study of Gemcitabine and Oxaliplatin in Combination With Bevacizumab in Patients With Advanced Hepatocellular Carcinoma

Andrew X. Zhu, Lawrence S. Blaszkowsky, David P. Ryan et al. · Journal of Clinical Oncology · 2006 · 388 citations

Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study

Andrew X. Zhu, Jeffrey A. Meyerhardt, Lawrence S. Blaszkowsky et al. · The Lancet Oncology · 2009 · 308 citations

Medicine, Biliary Cancer, Cancer Treatment +8

Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors

Jennifer A. Chan, Keith Stuart, Craig C. Earle et al. · Journal of Clinical Oncology · 2012 · 296 citations · Full text